Vigilare Biopharma Pvt Ltd’s Post

🌍💊 #MedSafetyWeek 2024 (4-10 November) is here! 💊🌍   At spmd - safety strategies for health, we’re proud to support the #UppsalaMonitoringCentre and other global regulatory bodies to promote Pharmacovigilance (PV) and the crucial act of reporting adverse drug reactions (ADRs).   Why is reporting ADRs so important?   🔹 It provides real-time data that helps identify new risks. 🔹 It ensures the safety of medicines by preventing serious health risks. 🔹 It empowers patients and healthcare professionals to contribute to a safer healthcare system.   "𝘠𝘰𝘶𝘳 𝘪𝘯𝘱𝘶𝘵 𝘮𝘢𝘵𝘵𝘦𝘳𝘴—𝘣𝘺 𝘳𝘦𝘱𝘰𝘳𝘵𝘪𝘯𝘨 𝘴𝘪𝘥𝘦 𝘦𝘧𝘧𝘦𝘤𝘵𝘴, 𝘺𝘰𝘶 𝘩𝘦𝘭𝘱 𝘳𝘦𝘨𝘶𝘭𝘢𝘵𝘰𝘳𝘴 𝘮𝘢𝘬𝘦 𝘪𝘯𝘧𝘰𝘳𝘮𝘦𝘥 𝘥𝘦𝘤𝘪𝘴𝘪𝘰𝘯𝘴 𝘵𝘩𝘢𝘵 𝘴𝘢𝘧𝘦𝘨𝘶𝘢𝘳𝘥 𝘱𝘶𝘣𝘭𝘪𝘤 𝘩𝘦𝘢𝘭𝘵𝘩."   📝 For the USA, the 𝗨.𝗦. 𝗙𝗼𝗼𝗱 𝗮𝗻𝗱 𝗗𝗿𝘂𝗴 𝗔𝗱𝗺𝗶𝗻𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 (𝗙𝗗𝗔) provided comprehensive information on how you can report side effects directly to health authorities: https://lnkd.in/etHpzD34   As a specialized PV service provider, we assist Sponsors and Marketing Authorization Holders in monitoring and managing the safety profiles of their products from discovery to post-marketing worldwide. This helps ensure that medicinal products continue to be safe for patients across the globe.   Learn more about how we support #PatientSafety and ensure robust pharmacovigilance systems at www.spmd-safety.com. Together, we can enhance the safety of drugs and medicines worldwide!   #MedSafetyWeek2024 #Pharmacovigilance #PatientSafety #SPMD #UppsalaMonitoringCentre #DrugSafety

Celebrating National Pharmacovigilance Week is crucial for enhancing awareness about adverse drug reactions (ADRs) and thus, ensuring Patient & Drug Safety. This year Indian Pharmacopoeia Commission focuses on the theme "Building ADR Reporting Culture for Patient Safety". For quality healthcare in India, it is important to foster a culture where healthcare professionals and patients feel empowered to report ADRs. #NPW2024 #patientsafety #drugsafety #healthcareinindia

Ahead of #MedSafetyWeek which begins tomorrow, my first campaign as a #medicinessafetyofficer, my pledge this year is to embed an open, transparent & constructive dialogue around all themes #MedSafety & that we share any learning this presents #courage #kindness #integrity Are you ready for #MedSafetyWeek?

In 2010, new European pharmacovigilance legislation was proposed for the European Union which came into effect in 2012, also leading to the installment of EMA’s Pharmacovigilance Risk Assessment Committee. In a recent scientific publication, a group of authors including MEB colleague and former PRAC chair Sabine Straus, reflected on the strengthened EU system for pharmacovigilance. They conclude that the legislation achieved its aim to strengthen patient and public health protection. The authors also set out a vison for the future, based on four principles to further progress the EU pharmacovigilance system: a compass to guide actions to build capacity, technology and methods and to improve regulatory processes. More in the article - The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System #regulatoryscience #pharmacovigilance Priya Bahri Georgy Genov Peter Arlett Viola Macolic Sarinic Evdokia Korakianiti Alexis Nolte Martin Huber https://lnkd.in/e9PcWVZJ

#MedSafetyWeek 💊 💉 💊 💉 All medicines can cause #SideEffects 🤢. You can help prevent them by taking your medicines as instructed, in the right dose, at the right time, and in the right way. Also, if #Roche #Ireland #Dublin 🇮🇪 Regulatory Affairs could refrain from perpetrating "ERRORS" (sic) ❗ 😅 with #PatientSafety and #pharmacovigilance rules... (see attached article). #PatientsDeserveBetter 🇮🇪 dear Roche 🇨🇭 Genentech 🇺🇸 , Health Products Regulatory Authority (HPRA), FDA, Simon Harris & Stephen Donnelly To know more and to report side effects (aka Adverse Drug Reactions) to Health Authorities, please check out European Medicines Agency's 🇪🇺 Eudravigilance ➡️ https://lnkd.in/eZttdFhk

Dear Jennifer Foster, many thanks for your comment that says : "the cost of losing one's life for a period of time is much greater." Roche #pharmaceuticals 🇨🇭 has endangered #PatientSafety in #Ireland 🇮🇪 , in infringement with #pharmacovigilance regulations, by providing Irish healthcare professionals and patients with non-compliant marketing materials that failed to provide full comprehensive accurate updated safety information on its marketed medicines, thus misrepresenting the benefits / risks balance of its medicines, out of commercial purposes.   There is absolutely no space for compromising patient safety allowed in the law.   My primary concern as a healthcare professional has always been to genuinely protect patients. But, instead of meeting a company ready to do the right thing, once I performed protected disclosures of their wrongdoing putting patient safety at risk, Roche tried to protect themselves before patients. Roche did not like that I disrupted the status quo, that did not take proper care of patient safety.   I was penalized by Roche for speaking up and making allegations of wrongdoings, for being a #whistleblower, i.e. the #snitch that exposed them. I was heavily victimized in retaliation. I was the snitch to be managed out.   It was totally violent. Roche was incredibly and unbearably violent with me.   Roche put me in an impossible situation in the first place. But, I had absolutely no choice. All I’ve done at Roche was being true to my unwavering commitment to protecting patient safety.   Ultimately, that has left me destroyed and still unable to bounce back. Roche has destroyed my life.   #MedSafetyWeek 💊 💉 #PatientsDeserveBetter #Roche Health Products Regulatory Authority (HPRA) 🇮🇪 Simon Harris 🇮🇪 Stephen Donnelly 🇪🇺 European Medicines Agency 🇪🇺 European Commission

Interesting topic in this post with a link to a short podcast about under reporting in PV and actions being/can be taken to strengthen and support reporting ✅️ #pharmacovigilance #DrugSafetyMatters #MedSafetyWeek

It’s #MedSafetyWeek this November 4th! 🩺💊 Did you know that reporting adverse drug reactions can make medicines safer for everyone? Uppsala Monitoring Centre’s post shows why your voice matters—let’s help spread the word! 🌍 #Pharmacovigilance #DrugSafety

Day 2 of World Drug Safety Congress Americas in Boston, US continues to be enriched with insights from different regulatory agencies including Health Canada, FDA and EU regulators. The final key note- One world, one standard: The future of pharmacovigilance is being discussed live by this panel. The availabilty of patient safety data from payor databases to regulators has major implications for PV professionals. #healthcanada #drugsafety #patientsafety

New Health Canada Foreign Actions Reporting Requirements Got You Scrambling? Starting Oct 28, PV teams in Canada must report foreign actions via FDA gateway following REP – and many are struggling to keep up with the sudden changes.   💡 Join us at our DIA Canada booth on Nov 14-15 to see how ZENITH PV can make Foreign Actions Reporting automatic and easy. Our solution enables real-time alerts from global regulatory agencies, transforming foreign action reporting into a seamless, hands-free process. Stop by Zenith PV booth for: 🔹10-Min Rapid Consult to answer your compliance questions 🔹 Interact with our Founder, Manar Hammood or our team and see how you can be ready for this change Contact us to secure a time slot at info@zenithpv.ca #DIACanada #pharmacovigilance #HealthCanada #CESG #RegulatoryCompliance #ZenithPV